Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study of Tolerability and Preliminary Efficacy of Galantamine to Treat Metabolic Syndrome in People With Chronic Traumatic Spinal Cord Injury (SCI)

NCT07625332 is registered in ClinicalTrials.gov with Northwell Health as lead sponsor.

NCT NCT07625332
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07625332 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study of Tolerability and Preliminary Efficacy of Galantamine to Treat Metabolic Syndrome in People With Chronic Traumatic Spinal Cord Injury (SCI)
Lead sponsor
Northwell Health
Phase
Phase 2/3
Overall status
Recruiting
Start date
June 15, 2026
Completion date
December 31, 2027
Enrollment
60 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

metabolic syndrome, paraplegia and tetraplegia, spinal cord injury, traumatic spinal cord injury